Trevi Therapeutics Inc
TRVI
$13.86+1.69%
At close · Nov 3, 2026
Mkt cap
$2.32B
EV/Sales
—
P/E ratio
—
Revenue (FY2025)
—
EPS (H1 2026)
−$0.21
Gross Margin (FY2025)
—
Profit Margin (FY2025)
—
Beta
—
Div yield
—
Sector
Healthcare
TRVI at a glance
TRVI AI brief
AIOverview
What matters now, from SEC filings and analyst ratings
Takeaway
A takeaway appears here once the latest filing has been analyzed.
Latest
TRVI earnings
Analysts
RatingsQuant grade metrics
Sector-relative grades for valuation, growth, profitability, momentum and revisions
Financials
Earnings
Ownership
Insiders
Form 4 trades, last 90 days
Filings
Latest SEC filings
No recent SEC filings on file.
News
Latest stored headlines
TRVI — Trevi Therapeutics Inc · $2.32B cap
TRVI Key Statistics
- Market Cap: $2.32B
- P/B Ratio: 13.5
- Previous Close: $13.63
- Volume: 1,182,089
- Day Range: $13.74 – $14.23
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Use this TRVI research hub for sector, financials, and filings — not a live tape.
Trevi Therapeutics Inc latest statements (FY2025)
Latest cached year on this hub. Full TRVI income, balance, and cash tables.
- Net Income-$42.8M
- Total Assets$193.4M
- Free Cash Flow-$42.1M
TRVI FAQ
What industry is TRVI in?
Trevi Therapeutics Inc (TRVI) is a biotechnology company in the Healthcare sector.
What is TRVI's latest net income?
Latest cached Trevi Therapeutics Inc (TRVI) net income for FY2025 was -$42.8M. Statements: https://lician.com/financials/trvi
What is TRVI's market cap?
Trevi Therapeutics Inc (TRVI) market capitalization is $2.32B on the latest cached snapshot.
What are TRVI's previous close, day range, and volume?
Trevi Therapeutics Inc (TRVI) cached previous close $13.63; day range $13.74 – $14.23; volume 1,182,089. Session quote: https://lician.com/quote/trvi
When was TRVI's latest earnings event?
Trevi Therapeutics Inc (TRVI) latest cached earnings event is "TRVI earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings